Interview with Ali Akyildiz, General Manager, IMS Health Turkey
Before we start with the interview I noticed that previously you were in charge of other regions aside from turkey.…
IMS Health Turkey
Last updated: 15.06.2015
IMS started to operate in Turkey through some other local companies in the late 60s. The first report was published in 1968. Since the inception of the local entity in 1990, it has grown significantly serving both local and multinational clients by providing information, technology solutions and professional services including consulting. Our information panel covers over 99% of the market in terms of pharmaceutical sales data and accepted as a gold standard in the industry. Our consulting team consists of 20 professional consultants and acting as a hub for Middle East to support our clients in solving their problems in portfolio strategy, market entry, mergers & acquisitions and commercial effectiveness.
Currently, IMS Turkey is serving more than 150 clients in these areas with about 140 professionals with our recent Cegedim acquisition.
Contact Details
Gazeteciler Mahallesi
Yazarlar Sokak – No. 8, 34394 Esentepe – Sisli
Istanbul
Turkey
Tel: +90 212 355 57 00
Interviews
Related
Muzzafer Bal – CEO, Ali Raif
Muzaffer Bal, CEO of Ali Raif, a Turkish generics firm, highlights the company’s new investment in a…
Turkey / Abdi Ibrahim CEO Talks Biosimilars, M&A, & US Entry
Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s…
Hatice Öncel – CEO, Ilko Pharmaceuticals
Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel…
Hamdi Akan – Head of the Executive Board, Clinical Research Association,…
Dr Hamdi Akan, head of Turkey’s Clinical Research Association, dives into the country’s opportunities and…
Ismail Yormaz – VP & Regional Director South-East, Recordati
Ismail Yormaz, Recordati’s VP and regional director for south-east, highlights how the Milan-based company has…
Turkey / How Pricing is Straining Turkish Pharma’s Sustainability
Almost two decades after initiating large-scale health system reforms, Turkey has consolidated the provision of…
Şeyda Atadan Memiş – General Manager, Takeda Turkey
Takeda’s general manager for Turkey, Şeyda Atadan Memiş, reflects on the Japanese giant’s ambitions in Turkey…
Tolga Karakan – President, Turkish Medicines and Medical Devices Agency…
TITCK is the regulatory agency in charge of ensuring the safety of medicines, health products, cosmetics, and…
Pharma Faces / Demet Russ, Janssen Turkey
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen…
Avinash Potnis – Managing Director, Novartis Pharma Turkey
Avinash Potnis of Novartis Turkey discusses potential solutions to the country’s access and pricing dilemma which…
Ingrid Drechsel – Pharma Cluster Division Head, Bayer Turkey & Iran
Ingrid Drechsel, head of Bayer’s pharma operations in Turkey and Iran, discusses the complexity of managing two…
Uğur Bingöl – General Manager Turkey, Middle East and Africa, Menarini
Menarini’s general manager for Turkey, the Middle East and Africa Uğur Bingöl discusses the Italian company’s…
